TITLE:
Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

CONDITION:
Alzheimer's Disease

INTERVENTION:
MK0677

SUMMARY:

      An investigational drug (MK0677) will be studied to determine whether it helps the memory
      and cognition of patients with Alzheimer's Disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 50 Years to N/A
Criteria:

        -  Patients must have probable Alzheimer's disease of mild or moderate severity.

          -  A brain scan and laboratory results must be consistent with Alzheimer's disease.

          -  The patient must be otherwise medically healthy.
      
